FAQ on Increased Healthcare Use Before MS Diagnosis
Summary
What does the study reveal about healthcare use before MS diagnosis?
The study found that individuals who are later diagnosed with MS visit doctors, hospitals, and emergency rooms more frequently decades before their diagnosis compared to those who do not develop MS.
How long before diagnosis do these increased healthcare visits occur?
These increased healthcare visits often occur more than 20 years before an MS diagnosis is made.
Why is early detection of MS important?
Early detection allows patients to benefit sooner from medications being developed to address MS, potentially improving outcomes.
What are the implications of this study for MS diagnosis?
The study suggests that a high frequency of medical attention for certain health problems earlier in life could serve as early warning signs for MS, enabling earlier diagnosis and treatment.
Who is involved in developing medications for MS mentioned in the content?
Companies like Clene Inc. (NASDAQ: CLNN) are mentioned as developing medications to address MS.
Where can I find more information about Clene Inc.?
The latest news and updates relating to Clene Inc. are available in the company’s newsroom at https://ibn.fm/CLNN.
What is BioMedWire?
BioMedWire is a specialized communications platform focusing on the latest developments in Biotechnology, Biomedical Sciences, and Life Sciences sectors, providing news and updates to a wide audience.
How can I receive alerts from BioMedWire?
To receive SMS alerts from BioMedWire, text ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only).
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 109048